OTI: Module 2: Timely Therapy Intensification: Tools to Guide Better Decision-Making at the Point of Care
During this module our presenters will discuss evidence supporting the value of timely therapy optimization to achieving glycemic targets and the legacy effect in type 2 diabetes. This discussion will focus on integrating the ADA type 2 diabetes medication algorithm with effective intensification and deintensification guidance for reducing therapeutic inertia. In order to encourage collaborative decision making between patients, team members, and primary care providers, presenters will provide practical techniques for how and when to use new tools and technology. These include CGM, time in range, and updated medication delivery systems.
At the conclusion of this activity, participants should be able to:
- Understand evidence supporting the legacy effect of reaching glycemic targets and A1C goal quickly after diagnosis
- Describe the optimal process for intensifying and deintensifying medication therapy that quickly and effectively yields optimal diabetes targets in type 2 diabetes
- Define how decision support tools and technology can be used to assist the patient-provider team in achieving glycemic targets and overall health
Acknowledgement of Commercial SupportThis activity is supported by an unrestricted educational grant from Novo Nordisk & Merck Co., Inc.
RELATED ACTIVITIESAmerican Diabetes Association: Overcoming Therapeutic Inertia Certificate Program
AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.